Regulatory expectations for patient input in drug development have shifted from aspiration to documented methodology across three major jurisdictions.
News|Webcasts|October 11, 2024
Insight-Driven Strategies: Elevating Patient Centricity in Clinical Trials
Author(s)IQVIA
Webinar Date/Time: Wednesday, November 13th, 2024 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Join experts from IQVIA Biotech and IQVIA in a webinar focused on enhancing clinical trial conduct by prioritizing patient-centric approaches. Discover innovative strategies for recruiting and retaining diverse patient populations and learn how to operationalize insights to meet accessibility goals. Don’t miss this opportunity to gain valuable insights and improve trial outcomes!
Register Free:
In this webinar, experts from IQVIA Biotech and IQVIA will focus on enhancing site and country trial conduct by putting the patient at the heart of their studies. Explore solutions to the challenges faced in recruiting and retaining diverse patient populations and see how insights are operationalized to meet patient accessibility goals. We look forward to your participation!
Three key take-aways
- Importance of patient voice: Learn how integrating patient perspectives can improve trial outcomes and support an innovative patient-centric culture.
- Patient engagement strategies: Discover innovative approaches to recruit and engage participants and the strategic site support that fosters effective workflows among sponsors, sites and patients.
- Enhancing trial success through design and execution: Gain insights on clinical trial country prioritization and rethink your strategy, operations and delivery model to enhance diversity and trial success.
Speakers:
Erin Finot, M.S., MBA
Vice President, Immuno-Oncology and CAGT
Erin Finot, M.S., MBA, vice president of immuno-oncology and CAGT at IQVIA Biotech, leads strategic efforts to ensure high-quality services and innovative trial solutions for biotech sponsors. With over 20 years of experience in global clinical research and drug development, Finot’s therapeutic expertise guides sponsors through the dynamic landscape of immuno-oncology and cell and gene therapies.
Katie Shaw
Senior Director, Site & Patient Networks, Clinical Operations
In her role as senior director of site and patient networks for clinical operations at IQVIA, Katie Shaw is accountable for the data-driven strategy development and operational pull-through for the patient recruitment and enablement solutions. Shaw leverages 15 years of experience in the clinical research industry, specializing in patient recruitment and retention innovation in the areas of data science, technology and patient engagement, and operational integration of IQVIA strategies, products and services across the global multidisciplinary teams, sites and with customers who leverage IQVIA solutions.
Register Free:
Related to this article
In a video interview prior to the 2026 DPHARM conference, Andrea Valente, CEO of uMotif, shares what she expects to be at the center of the conversation—from building trust between patients and sites to where AI may and may not have a role in that relationship.
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, explains why the full burden of developmental and epileptic encephalopathies extends far beyond clinical symptoms—and why endpoints must reflect what families are actually hoping for.
Participant engagement depends more on clarity and understanding than on gamification or incentives, requiring engagement embedded into trial workflows as a core design component rather than a peripheral consideration
In a video interview prior to the 2026 DPHARM conference, Andrea Valente, CEO of uMotif, explains why the real technology challenge isn't usability alone—it's making it easier for patients and sites to interact more effectively with each other.
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.
Why clinical development’s next AI bottleneck is not the model, but the system around it.
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.